Lotus Eye Hospital and Institute Performance
- Today's Low
- ₹124
- Today's High
- ₹130
- 52 Week Low
- ₹70
- 52 Week High
- ₹147
- Open Price₹129
- Previous Close₹128
- Volume5,657
- 50 DMA₹119.38
- 100 DMA₹116.27
- 200 DMA₹110.68
Lotus Eye Hospital and Institute Chart
Investment Returns
- Over 1 Month + 14.26%
- Over 3 Month + 18.7%
- Over 6 Month -2.45%
- Over 1 Year + 74.88%
Smart Investing Starts Here Start SIP with Lotus Eye Hospital and Institute for Steady Growth!
Lotus Eye Hospital and Institute Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 3233.8
- PEG Ratio
- -36.3
- Market Cap Cr
- 260
- P/B Ratio
- 4.3
- Average True Range
- 7.56
- EPS
- 0.04
- Dividend Yield
- 0
- MACD Signal
- 4.7
- RSI
- 52.34
- MFI
- 82.78
Latest Stock News Updates
- Moneycontrol
- 2 years 10 months ago
NULL
- Moneycontrol
- 4 years 4 months ago
NULL
- Moneycontrol
- 5 years 4 months ago
Lotus Eye Hospital and Institute Financials
Lotus Eye Hospital and Institute Technicals
EMA & SMA
- Bearish Moving Average 5
- Bullish Moving Average 11
- 20 Day
- ₹125.00
- 50 Day
- ₹119.40
- 100 Day
- ₹116.30
- 200 Day
- ₹110.70
Resistance and Support
- R3 134.00
- R2 131.79
- R1 128.41
- S1 122.82
- S2 120.61
- S3 117.23
Lotus Eye Hospital and Institute Corporate Actions - Bonus, Splits, Dividends
About Lotus Eye Hospital and Institute
- NSE Symbol
- LOTUSEYE
- BSE Symbol
- 532998
- Managing Director
- Ms. Sangeetha Sundaramoorthy
- ISIN
- INE947I01017
Similar Stocks to Lotus Eye Hospital and Institute
Popular Stocks
Lotus Eye Hospital and Institute FAQs
Lotus Eye Hospital and Institute share price is ₹125 As on 27 June, 2026 | 12:18
The Market Cap of Lotus Eye Hospital and Institute is ₹260 Cr As on 27 June, 2026 | 12:18
The P/E ratio of Lotus Eye Hospital and Institute is 3233.8 As on 27 June, 2026 | 12:18
The PB ratio of Lotus Eye Hospital and Institute is 4.3 As on 27 June, 2026 | 12:18
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.